Ownership history in CITADEL ADVISORS LLC · 16 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in BIOSHARES BIOTECHNOLOGY CLIN (BBC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 40,923 | +6,292 | +18.2% | 0.00% | $1.6M | $38.56 |
| 2024 Q3 | REDUCED | 34,631 | -5,469 | -13.6% | 0.00% | $968K | $27.21 |
| 2024 Q2 | ADDED | 40,100 | +2,773 | +7.4% | 0.00% | $1.0M | $24.60 |
| 2023 Q4 | ADDED | 37,327 | +1,815 | +5.1% | 0.00% | $913K | $23.81 |
| 2023 Q3 | ADDED | 35,512 | +1,824 | +5.4% | 0.00% | $697K | $19.04 |
| 2023 Q2 | ADDED | 33,688 | +925 | +2.8% | 0.00% | $807K | $23.25 |
| 2023 Q1 | ADDED | 32,763 | +19,962 | +155.9% | 0.00% | $718K | $21.27 |
| 2020 Q4 | ADDED | 12,801 | +2,083 | +19.4% | 0.00% | $635K | $48.11 |
| 2020 Q3 | REDUCED | 10,718 | -3,233 | -23.2% | 0.00% | $418K | $37.82 |
| 2019 Q3 | ADDED | 13,951 | +5,834 | +71.9% | 0.00% | $332K | $23.11 |
As of 2025 Q4 — sorted by position size